Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: Hexylaminolevulinate and Aminolevulinic Acid Nano Emulsion Versus Methylaminolevulinate
Sponsor: Joint Authority for Päijät-Häme Social and Health Care
A PHASE1/PHASE2 clinical study on Carcinoma, Basal Cell and Neoplasms, Basal Cell, this trial is ongoing. The trial is conducted by Joint Authority for Päijät-Häme Social and Health Care and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Unknown PHASE1/PHASE2
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Sep 2018 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Joint Authority for Päijät-Häme Social and Health Care
- Tampere University
- University of Jyvaskyla
For direct contact, visit the study record on ClinicalTrials.gov .